Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Analgesia After Cardiac Surgery
NCT06619145Phase 4Not yet recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Nov 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in postoperative pain, sponsored by Nanjing First Hospital. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06619145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06619145.